These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 25365435)

  • 21. Discontinuation rates of menopausal hormone therapy among postmenopausal women in the post-WHI study era.
    Kyvernitakis I; Kostev K; Hars O; Albert US; Hadji P
    Climacteric; 2015 Oct; 18(5):737-42. PubMed ID: 25845443
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Is there a role for menopausal hormone therapy in the management of postmenopausal osteoporosis?
    Rozenberg S; Al-Daghri N; Aubertin-Leheudre M; Brandi ML; Cano A; Collins P; Cooper C; Genazzani AR; Hillard T; Kanis JA; Kaufman JM; Lambrinoudaki I; Laslop A; McCloskey E; Palacios S; Prieto-Alhambra D; Reginster JY; Rizzoli R; Rosano G; Trémollieres F; Harvey NC
    Osteoporos Int; 2020 Dec; 31(12):2271-2286. PubMed ID: 32642851
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Risks and benefits of postmenopausal hormone replacement therapy].
    Szántó F
    Orv Hetil; 1998 Nov; 139(44):2639-42. PubMed ID: 9842237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Postmenopausal hormone therapy and the risk of cardiovascular disease.
    Stramba-Badiale M
    J Cardiovasc Med (Hagerstown); 2009 Apr; 10(4):303-9. PubMed ID: 19430340
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Menopausal hormone therapy: currently no evidence for cardiac protection.
    Wenger NK
    Pediatr Blood Cancer; 2005 Jun; 44(7):625-9. PubMed ID: 15747336
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Implications of recent clinical trials of postmenopausal hormone therapy for management of cardiovascular disease.
    Rossouw JE
    Ann N Y Acad Sci; 2006 Nov; 1089():444-53. PubMed ID: 17261787
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Postmenopausal hormone therapy: cardiovascular risks.
    Prescrire Int; 2003 Apr; 12(64):65-9. PubMed ID: 12674130
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hormone therapy and cardiovascular disease--still much to be learnt.
    Mikkola TS; Ylikorkala O
    Gynecol Endocrinol; 2005 Feb; 20(2):116-20. PubMed ID: 15823832
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hormone replacement therapy and cardioprotection: what is good and what is bad for the cardiovascular system?
    Rosano GM; Vitale C; Fini M
    Ann N Y Acad Sci; 2006 Dec; 1092():341-8. PubMed ID: 17308159
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Emerging role of estrogen in the control of cardiometabolic disease.
    Cignarella A; Kratz M; Bolego C
    Trends Pharmacol Sci; 2010 Apr; 31(4):183-9. PubMed ID: 20138672
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The applicability of hormonal effects on atherosclerosis in animals to heart disease in postmenopausal women.
    Wagner JD; Clarkson TB
    Semin Reprod Med; 2005 May; 23(2):149-56. PubMed ID: 15852200
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The benefits and risks of hormonal replacement therapy--an update].
    Schmidt M; Kimmig R
    Gynakol Geburtshilfliche Rundsch; 2006; 46(4):166-73. PubMed ID: 17068401
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hormone replacement therapy and secondary cardiovascular prevention: a meta-analysis of randomized trials.
    Cho L; Mukherjee D
    Cardiology; 2005; 104(3):143-7. PubMed ID: 16118493
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Is There a Role for Menopausal Hormone Therapy (MHT) for Cardiovascular Disease Prevention in Select Postmenopausal Women?
    Cutchins A; Wenger NK
    Curr Treat Options Cardiovasc Med; 2013 Dec; 15(6):722-34. PubMed ID: 23861019
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Investigative models for determining hormone therapy-induced outcomes in brain: evidence in support of a healthy cell bias of estrogen action.
    Brinton RD
    Ann N Y Acad Sci; 2005 Jun; 1052():57-74. PubMed ID: 16024751
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Is there a place for postmenopausal hormone therapy use in women with lupus?
    Gompel A; Piette JC
    Panminerva Med; 2008 Sep; 50(3):247-54. PubMed ID: 18927529
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Postmenopausal hormone-replacement therapy discredited, except in healthy women shortly after menopause].
    Maas AH; van der Graaf Y
    Ned Tijdschr Geneeskd; 2002 Nov; 146(45):2127-30. PubMed ID: 12474550
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Biological and practical aspects of hormone replacement therapy: an approach to cardiovascular disease prevention in postmenopausal women].
    da Silva PM
    Rev Port Cardiol; 1999 Nov; 18(11):1047-55. PubMed ID: 10608165
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hormone therapy in the WHI era.
    Burger HG
    Aust N Z J Obstet Gynaecol; 2006 Apr; 46(2):84-91. PubMed ID: 16638027
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A heartfelt message, estrogen replacement therapy: use it or lose it.
    Speth RC; D'Ambra M; Ji H; Sandberg K
    Am J Physiol Heart Circ Physiol; 2018 Dec; 315(6):H1765-H1778. PubMed ID: 30216118
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.